Market revenue in 2023 | USD 247.0 million |
Market revenue in 2030 | USD 320.5 million |
Growth rate | 3.8% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.34% in 2023. Horizon Databook has segmented the Asia Pacific in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific portrays a high potential for this market majorly due to the increasing number of companies getting involved in the manufacturing of IVDs and IVD quality control products. Moreover, a rise in awareness for early and precise diagnosis fosters the demand for IVDs.
For instance, the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine (APFCB) is engaged in promoting awareness about the use of IVDs through several committees. Moreover, regulatory authorities at a country level.
The Pharmaceuticals and Medical Devices Evaluation Agency (PMDA), the National Medical Products Administration (NMPA), the Central Drugs Standard Control Organization (CDSCO), and others, are undertaking favorable initiatives to increase the market penetration of IVD and IVD quality control products.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific in vitro diagnostics quality control market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account